Aletheia Life Science Consulting

About Aletheia Life Science Consulting

Early-stage biotech companies face a dual challenge: they must convince regulators, investors, and scientific peers of their innovation’s potential with limited resources and time. Structuring and ensuring your data are fit for purpose is a major hurdle: research data is often scattered, unstructured, and difficult to assess for regulatory or market relevance. Secondly, companies struggle with marketing fundamentals: building a consistent brand, tailoring messages to different audiences, and communicating complex science in a way that resonates. Without clarity in both data and communication, even groundbreaking innovations risk stalling before they reach the clinic. At Aletheia, our mission is to empower biotech innovators by bridging science, strategy, and communication. With decades of combined experience in drug development, regulatory affairs, marketing, and scientific storytelling, we know how to navigate the early development landscape. Our vision is to help promising therapies reach patients faster by ensuring that companies design the right development path and communicate their value with clarity and impact. We achieve this with a strong focus on efficiency and cost-effectiveness; streamlining development plans, accelerating decision-making, and reducing wasted effort. In doing so, every step delivers measurable progress while saving valuable time and resources. To achieve this, we offer three integrated service pillars tailored from discovery to clinical stage. Drug Development Consultancy – from regulatory advice and strategic planning to Phase I readiness, study design, and guidance during investor and agency meetings. Brand Development – building the foundations of a strong identity, web presence, messaging, and recruitment support for clinical trials. Scientific Communication – creating visibility and trust through press releases, content marketing, webinars, KOL engagement, conferences, and speaking opportunities.